By The Discovering... - Posted on July 22nd, 2007
Three of Purdue Pharma’s top executives were sentenced last week for their roles in misrepresenting Oxycontin, a powerful pain killing opioid, to the medical community and general public. They were convicted of a litany of charges including:
The charges included several illegal schemes to promote, market and sell OxyContin as being less likely to cause abuse, addiction, tolerance and withdrawal than other pain medications. In particular, it is reported that Purdue trained its sales representatives to make false representations to health care providers about the difficulty of extracting oxycodone, the active ingredient, from the OxyContin tablet thereby decreasing the potential for abuse, and that a lack of euphoria rendered it less addictive than immediate-release opiates and morphine. In addition, Purdue falsely labeled OxyContin as providing "fewer peaks and valleys than with immediate-release oxycodone," and falsely represented that patients taking lower dosages of the drug can always be discontinued abruptly without suffering withdrawal symptoms or tolerance.
Purdue Pharma as a private company had already been penalized with $600 million in fines for the criminal activities. In my opinion, this should have characterized the seriousness of the crimes and been followed by draconian sentences for the three executives that orchestrated the crimes. Unfortunately it was not to be, none of the executives will set foot in prison with the worst of their sentences being probation and community service.
Click "Read more" to continue the story...